Product TypeFlash Report Product TypeFlash Report | August 2, 2016 Register for Free Access CVS Pharmacy (CVS) 2Q16 Results: Mixed Quarter, but Company Raises GuidanceCVS reported 2Q16 adjusted EPS of $1.32, up 8.3% year over year and ahead of guidance of $1.28–$1.31, beating the consensus estimate by two cents. The company reported revenues of $43.7 billion, up 17.6% year over year but missing the $44.3 billion consensus estimate.Read More
Product TypeFlash Report Product TypeFlash Report | April 5, 2016 Register for Free Access Walgreens Boots Alliance (WBA) 2Q16 Results: In-Line Results Driven by Strong Pharmacy BusinessWalgreens Boots Alliance reported fiscal 2Q16 revenues of $30.2 billion, up 13.6% from the year-ago period and slightly below the consensus estimate of $30.7 billion. Adjusted EPS was $1.31, up 10.8% year over year and slightly above the consensus estimate of $1.28.Read More
Product TypeFlash Report Product TypeFlash Report | February 10, 2016 Register for Free Access CVS Health (CVS) 4Q15 Results: Strong Growth Aided by AcquisitionsCVS Health reported that 4Q15 net sales rose by 11.0% year over year, to $41.1 billion, slightly above the consensus estimate of $41.0 billion. Read More
Product TypeCompany Earnings Update Product TypeCompany Earnings Update | December 16, 2015 Register for Free Access CVS Pharmacy Analyst Day TakeawaysCVS Health held an Analyst Day in New York today. In attendance from the company were President and CEO Larry Merlo, EVP and CFO Dave Denton, President of CVS/caremark Jon Roberts, EVP of CVS/Specialty Pharmacy Alan Lotvin, President of CVS/pharmacy Helena Foulkes and President of Omnicare Rocky Kraft.Read More
Product TypeFlash Report Product TypeFlash Report | October 28, 2015 Register for Free Access Walgreens to Acquire Rite Aid in $17.2 Billion DealTuesday, Oct. 27, after the market close, Walgreens Boots Alliance announced an agreement to acquire smaller drugstore chain Rite Aid for $9.4 billion in cash, offering $9 per share in cash, which represents a 48% premium to Rite Aid’s closing price of $6.08 on Monday.Including debt, the deal is valued at $17.2 billion, the company said.Read More
